RAB7A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.513600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.659600E-01
Normal-vs-Stage2
9.762200E-01
Normal-vs-Stage3
6.575600E-01
Normal-vs-Stage4
4.182000E-01
Stage1-vs-Stage2
7.333800E-01
Stage1-vs-Stage3
6.340800E-01
Stage1-vs-Stage4
1.324760E-01
Stage2-vs-Stage3
3.935800E-01
Stage2-vs-Stage4
8.733700E-02
Stage3-vs-Stage4
2.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.081200E-01
Normal-vs-AfricanAmerican
9.570800E-01
Normal-vs-Asian
9.640200E-01
Caucasian-vs-AfricanAmerican
7.936200E-01
Caucasian-vs-Asian
8.990200E-01
AfricanAmerican-vs-Asian
8.878400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.420400E-01
Normal-vs-Female
9.631400E-01
Male-vs-Female
8.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.285200E-01
Normal-vs-Age(41-60Yrs)
5.686600E-01
Normal-vs-Age(61-80Yrs)
7.130800E-01
Normal-vs-Age(81-100Yrs)
9.851400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.637230E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.808800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.383600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.118020E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.683200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.305600E-01
Normal-vs-Daily Drinker
6.003400E-01
Normal-vs-Weekly Drinker
8.441800E-01
Normal-vs-Occasional Drinker
6.504400E-01
Normal-vs-Social Drinker
9.391200E-01
Non Drinker-vs-Daily Drinker
7.923600E-01
Non Drinker-vs-Weekly Drinker
3.691600E-01
Non Drinker-vs-Occasional Drinker
3.114000E-02
Non Drinker-vs-Social Drinker
1.513600E-01
Daily Drinker-vs-Weekly Drinker
5.070600E-01
Daily Drinker-vs-Occasional Drinker
6.548400E-02
Daily Drinker-vs-Social Drinker
2.305200E-01
Weekly Drinker-vs-Occasional Drinker
2.435200E-01
Weekly Drinker-vs-Social Drinker
6.099000E-01
Occasional Drinker-vs-Social Drinker
3.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.348400E-01
Normal-vs-Grade 2
4.830000E-01
Normal-vs-Grade 3
4.723800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.297450E-03
Grade 1-vs-Grade 3
3.504700E-03
Grade 1-vs-Grade 4
2.348400E-01
Grade 2-vs-Grade 3
7.110400E-01
Grade 2-vs-Grade 4
4.830000E-01
Grade 3-vs-Grade 4
4.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.256200E-01
Normal-vs-NonDiabetic
9.124200E-01
Diabetic-vs-NonDiabetic
3.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.777600E-01
Normal-vs-NoPancreatitis
8.651400E-01
Pancreatitis-vs-NoPancreatitis
2.411200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.066800E-01
Normal-vs-N1
9.955800E-01
N0-vs-N1
6.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.392400E-01
Normal-vs-TP53-NonMutant
3.758200E-01
TP53-Mutant-vs-TP53-NonMutant
5.82789999999944E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
